Can churches help prevent suicide in black communities? new study tests a Multi-Generational program

NCT ID NCT07401940

Recruiting now Prevention Sponsor: George Washington University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 21, 2026 · Updated 3 times

Summary

This study tests a suicide prevention program called HAVEN-Connect in African American churches. The program teaches youth and adults skills to build supportive relationships, find purpose, and seek help. Researchers will enroll 240 participants from predominantly Black churches to see if the program reduces depression and suicide risk. The goal is to create a culturally relevant approach that can be used in other churches.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: HAVEN-Connect program (behavioral intervention: youth and adult training on mental health support)
What this could lead to: If it works, this could provide a proven, culturally tailored way to prevent suicide in Black communities using churches as a trusted setting.
What could go wrong: This is an early-stage study with 240 participants, so results may not apply broadly. The program relies on church engagement, which may vary across communities.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUICIDE PREVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Suicide Prevention

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SUICIDE PREVENTION

Contacts and locations

Locations

Mt. Sinai Hospital; Ichon School of Medicine
RECRUITING

New York, New York, 10029, United States
University of Rochester Medical Center
RECRUITING

Rochester, New York, 14642-0002, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.